Risk of Radiation -Associated Secondary Malignancies among Patients with Breast Cancer Harboring TP53 Germline Variants

被引：0

作者：

Cederquist, G. ^{[1
]}

Boe, L. ^{[2
]}

Walsh, M. F. ^{[3
]}

Stadler, Z. ^{[4
]}

Xu, A. J. ^{[5
]}

Mueller, B. A. ^{[5
]}

O'Brien, D. A. Roth ^{[5
]}

Bernstein, M. B. ^{[5
]}

Cuaron, J. ^{[5
]}

Bakhoum, S. F. ^{[3
]}

Powell, S. N. ^{[5
]}

Khan, A. J. ^{[5
]}

Robson, M. E. ^{[4
]}

Maxwell, K. ^{[6
]}

Taunk, N. K. ^{[7
]}

Braunstein, L. Z. ^{[5
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Radiat Oncol, New York, NY USA

[2] Mem Sloan Kettering, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA

[6] Univ Penn, Philadelphia, PA USA

[7] Univ Penn, Hosp, Philadelphia, PA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

181

引用

页码：S45 / S46

页数：2

共 50 条

[41] Information and prevention needs among germline TP53(gTP53m)pathogenic variants carriers
Ben Ahmed, Tarek
Vidican, Pauline
Corradini, Nadege
Lasset, Christine
Goldbarg, Veronica
Guerrini-Rousseau, Lea
Claret, Beatrivr
Fervers, Beatrice
Rochefort, Pauline
Delaloge, Suzette
Caron, Olivier
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[42] New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
Evans, D. Gareth
Woodward, Emma R.
FAMILIAL CANCER, 2021, 20 (01) : 1 - 7
[43] New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
D. Gareth Evans
Emma R. Woodward
Familial Cancer, 2021, 20 : 1 - 7
[44] Germline TP53 mutations is common in patients with two early-onset primary malignancies
Chak, B. P.
Chan, E. S.
Tong, J. H.
Leung, A. W.
Cheng, F. W.
Lam, G. K.
Shing, M. M.
Li, C. K.
To, K. F.
CLINICAL GENETICS, 2015, 87 (05) : 499 - 501
[45] Molecular profile and clinical data of patients with lung cancer harboring germline TP53 R337H mutation
Lopes, C. D. H.
Antonacio, F. F.
Moraes, P. M. G.
Harada, G.
Gadia, R.
Jardim, D. L. F.
Katz, A.
Sandoval, R. L.
Achatz, M. I. A. D. S. W.
de Castro, G., Jr.
ANNALS OF ONCOLOGY, 2021, 32 : S1231 - S1232
[46] Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre
Henriett Butz
Anikó Bozsik
Vince Grolmusz
Erika Szőcs
János Papp
Attila Patócs
Scientific Reports, 13
[47] Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre
Butz, Henriett
Bozsik, Aniko
Grolmusz, Vince
Szocs, Erika
Papp, Janos
Patocs, Attila
SCIENTIFIC REPORTS, 2023, 13 (01)
[48] Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
Sheng, Shuyan
Xu, Ye
Guo, Yonghai
Yao, Lu
Hu, Li
Ouyang, Tao
Li, Jinfeng
Wang, Tianfeng
Fan, Zhaoqing
Fan, Tie
Lin, Benyao
Xie, Yuntao
INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 487 - 495
[49] Germline TP53 mutations in women with very early onset breast cancer (BR).
Masciari, S
Harris, L
Branda, K
Petkovska, A
Paez, J
Haber, D
Digianni, L
Sellers, W
Li, F
Garber, J
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 109S - 109S
[50] A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
Masaya Kai
Makoto Kubo
Sawako Shikada
Saori Hayashi
Takafumi Morisaki
Mai Yamada
Yuka Takao
Akiko Shimazaki
Yurina Harada
Kazuhisa Kaneshiro
Yusuke Mizuuchi
Koji Shindo
Masafumi Nakamura
Surgical Case Reports, 8

← 1 2 3 4 5 →